Further mechanistic insights reveal that the NLRP3 inflammasome may also contribute to chemoresistance; genetic ablation of NLRP3 enhances the antitumor efficacy of 5-fluorouracil (5-FU) in OSCC models, delaying tumor onset and reducing tumor burden (Pajak et al., 2017). Here, NLRP3 is linked to neoplasm.